HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E S Yu Selected Research

Liver Diseases (Liver Disease)

2/2001Results on preemptive or prophylactic treatment of lamivudine in HBsAg (+) renal allograft recipients: comparison with salvage treatment after hepatic dysfunction with HBV recurrence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E S Yu Research Topics

Disease

1Fibrosis (Cirrhosis)
09/2010
1Liver Cirrhosis (Hepatic Cirrhosis)
09/2010
1Infections
08/2001
1Liver Diseases (Liver Disease)
02/2001
1Viremia
02/2001
1Hepatitis
02/2001
1Hepatitis B
02/2001

Drug/Important Bio-Agent (IBA)

1oltiprazIBA
09/2010
1Pharmaceutical PreparationsIBA
09/2010
1Transforming Growth Factor beta1 (TGF beta 1)IBA
09/2010
1Lamivudine (Epivir)FDA Link
02/2001
1DNA (Deoxyribonucleic Acid)IBA
02/2001
1EnzymesIBA
02/2001

Therapy/Procedure

1Injections
08/2001
1Medical Day Care (Partial Hospitalization)
08/2001
1Transplantation
02/2001
1Kidney Transplantation
02/2001